scholarly journals Hypoparathyroidism, Retardation, and Dysmorphism Syndrome: Impaired Early Growth and Increased Susceptibility to Severe Infections Due to Hyposplenism and Impaired Polymorphonuclear Cell Functions

2007 ◽  
Vol 62 (4) ◽  
pp. 505-509 ◽  
Author(s):  
Eli Hershkovitz ◽  
Ilia Rozin ◽  
Yehuda Limony ◽  
Haim Golan ◽  
Nurit Hadad ◽  
...  
2007 ◽  
Vol 69 (4) ◽  
pp. 379-383 ◽  
Author(s):  
Katsura NODA ◽  
Hideo AKIYOSHI ◽  
Mica AOKI ◽  
Terumasa SHIMADA ◽  
Fumihito OHASHI

Nutrition ◽  
1996 ◽  
Vol 12 (2) ◽  
pp. 93-99 ◽  
Author(s):  
Dan L. Waitzberg ◽  
Raquel Bellinati-Pires ◽  
Nagamassa Yamaguchi ◽  
Sergio Massili-Oku ◽  
Maristela M. Salgado ◽  
...  

2021 ◽  
Author(s):  
Marine Peyneau ◽  
Vanessa Granger ◽  
Paul-Henri Wicky ◽  
Dounia Khelifi-Touhami ◽  
Jean-François Timsit ◽  
...  

AbstractCOVID-19 can cause acute respiratory distress syndrome (ARDS), leading to death in a significant number of individuals. Evidence of a strong role of the innate immune system is accumulating, but the precise cells and mechanism involved remain unclear. In this study, we investigated the links between circulating innate phagocyte phenotype and functions and severity in COVID-19 patients. Eighty-four consecutive patients were included, 44 of which were in intensive care units (ICU). We performed an in-depth phenotyping of neutrophil and monocyte subpopulations and measured soluble activation markers in plasma. Additionally, myeloid cell functions (phagocytosis, oxidative burst, and NETosis) were evaluated on fresh cells from patients. Resulting parameters were linked to disease severity and prognosis. Both ICU and non-ICU patients had circulating neutrophils and monocytes with an activated phenotype, as well as elevated concentrations of soluble activation markers (calprotectin, myeloperoxidase, neutrophil extracellular traps, MMP9, sCD14) in their plasma. ICU patients were characterized by increased CD10low CD13low immature neutrophils, LOX-1+ and CCR5+ immunosuppressive neutrophils, and HLA-DRlow CD14low downregulated monocytes. Markers of immature and immunosuppressive neutrophils were strongly associated with severity and poor outcome. Moreover, neutrophils and monocytes of ICU patients had impaired antimicrobial functions, which correlated with organ dysfunction, severe infections, and mortality. Our study reveals a marked dysregulation of innate immunity in COVID-19 patients, which was correlated with severity and prognosis. Together, our results strongly argue in favor of a pivotal role of innate immunity in COVID-19 severe infections and pleads for targeted therapeutic options.One Sentence SummaryOur study reveals a marked dysregulation of innate immunity in COVID-19 patients, which correlates with severity and prognosis.


2003 ◽  
Vol 65 (6) ◽  
pp. 727-729 ◽  
Author(s):  
Katsura NODA ◽  
Mika AOKI ◽  
Hideo AKIYOSHI ◽  
Hiroshi ASAKI ◽  
Terumasa SHIMADA ◽  
...  

2020 ◽  
Vol 79 ◽  
pp. 50-59
Author(s):  
Nisa Chuangchot ◽  
Chongchira Boonthongkaew ◽  
Wisitsak Phoksawat ◽  
Amonrat Jumnainsong ◽  
Chanvit Leelayuwat ◽  
...  

2020 ◽  
Author(s):  
Hakan Köksal ◽  
Pierre Dillard ◽  
Asta Juzeniene ◽  
Gunnar Kvalheim ◽  
Erlend B. Smeland ◽  
...  

AbstractCAR T cells targeting the B-lymphocyte antigen CD19 have led to remarkable clinical results in B-cell leukemia and lymphoma, but eliminate all B-lineage cells, leading to increased susceptibility to severe infections. As malignant B cells will express either immunoglobulin (Ig) light chain κ or λ, we designed a second-generation CAR targeting Igκ, IGK CAR. This construct demonstrated high target specificity, but displayed reduced efficacy in the presence of serum IgG. Since CD19 CAR is insensitive to serum IgG, we designed various combinatorial CAR constructs in order to maintain the CD19 CAR T cell efficacy, but with IGK CAR target selectivity. The Kz-19BB design, combining CD19 CAR containing a 4-1BB co-stimulatory domain with an IGK CAR containing a CD3zeta stimulatory domain, maintained the target specificity of IgK CAR and was resistant to the presence of soluble IgG. Our results demonstrate that a combinatorial CAR approach can improve target selectivity and efficacy.


2017 ◽  
Vol 41 (3) ◽  
pp. 201-209 ◽  
Author(s):  
Rafiqul Islam ◽  
Harendra Kumar ◽  
Gyanendra Singh ◽  
Binsila B. Krishnan ◽  
Sahadeb Dey

2003 ◽  
Vol 10 (2) ◽  
pp. 195-201 ◽  
Author(s):  
Taina Jaatinen ◽  
Meri Lahti ◽  
Olli Ruuskanen ◽  
Riikka Kinos ◽  
Lennart Truedsson ◽  
...  

ABSTRACT Deficiencies of the early components of the classical complement pathway impair the actions of innate and humoral immunity and may lead to increased susceptibility to infections. We have studied the genetic basis of total C4B deficiency in a Finnish patient with recurrent meningitis, chronic fistulas and abscesses. The maternal chromosome carried a four-gene deletion including the C4B gene, and a conversion from C4B to C4A gene was found on the paternal chromosome resulting in complete deficiency of C4B. In the converted C4A gene, mutation screening did not reveal any amino acid changes or prominent mutations, yet a large number of nucleotide variations were found. Further, the patient was heterozygous for structural deficiency of mannan binding lectin (MBL) associating with medium levels of serum MBL. Our data provides new information on the genetic instability of the C4 gene region, and on the association of homozygous C4B deficiency and variant MBL genotype with increased susceptibility to recurrent and chronic infections. Importantly, plasma therapy induced a prompt clinical cure with long-term effects.


2020 ◽  
pp. jbc.RA120.016234
Author(s):  
Hakan Köksal ◽  
Pierre Dillard ◽  
Asta Juzeniene ◽  
Gunnar Kvalheim ◽  
Erlend Bremertun Smeland ◽  
...  

CAR T cells targeting the B-lymphocyte antigen CD19 have led to remarkable clinical results in B-cell leukemia and lymphoma, but eliminate all B-lineage cells, leading to increased susceptibility to severe infections. As malignant B cells will express either immunoglobulin (Ig) light chain κ or λ, we designed a second-generation CAR targeting Igκ, IGK CAR. This construct demonstrated high target specificity, but displayed reduced efficacy in the presence of serum IgG.  Since CD19 CAR is insensitive to serum IgG, we designed various combinatorial CAR constructs in order to maintain the CD19 CAR T cell efficacy, but with IGK CAR target selectivity. The Kz-19BB design, combining CD19 CAR containing a 4-1BB co-stimulatory domain with an IGK CAR containing a CD3zeta stimulatory domain, maintained the target specificity of IgK CAR and was resistant to the presence of sIgG. Our results demonstrate that a combinatorial CAR approach can improve target selectivity and efficacy.


Sign in / Sign up

Export Citation Format

Share Document